Alex Azar

A federal appeals court has upheld a lower court decision blocking states' requirements that people must work in order to receive Medicaid.

Residents of Kentucky and Arkansas brought the action against Secretary of Health and Human Services Alex Azar, contending that Azar "acted in an arbitrary and capricious manner when he approved Medicaid demonstration requests for Kentucky and Arkansas."

The U.S. Court of Appeals for the District of Columbia Circuit agreed, writing in an opinion posted Friday that the secretary's authorization was indeed unlawful.

Updated 7:55 p.m. ET

The Trump administration declared a public health emergency in the U.S. Friday in response to the global coronavirus outbreak.

"Today President Trump took decisive action to minimize the risk of novel coronavirus in the United States," said U.S. Health and Human Services Secretary Alex Azar at a White House press conference.

The risk of contracting the coronavirus is the U.S. is low — something that federal health administration officials emphasized repeatedly. "We are working to keep the risk low," Azar said.

Updated 6:14 p.m. ET

The Trump administration announced it will crack down on certain vaping products containing fruit, mint and other e-cigarette flavors to keep them away from kids. Manufacturers will have 30 days to take these products off the market before the Food and Drug Administration can take enforcement action.

The Trump administration is calling on U.N. member nations to oppose efforts to promote access to abortion internationally, a move immediately criticized by reproductive rights groups seeking greater access to the services globally.

Health and Human Services Secretary Alex Azar has this pen. It's not all that remarkable looking, but he held it up multiple times Monday at a briefing with reporters.

"This pen," he said, "has a lot of power."

And he said he is prepared to use it.

Azar was making the point that in the area of drug prices, the head of HHS — which runs the Medicare and Medicaid programs and buys about $130 billion in prescription drugs each year — can make a lot of changes in the pharmaceutical market. And he doesn't need congressional approval to do it.

Updated at 1:48 p.m. ET

President Trump is nominating a former pharmaceutical executive to lead the Department of Health and Human Services, the agency that, among other things, regulates prescription drugs.

The nomination comes at a time when rising drug prices have become a hot political issue.